CClinicalTrials.gg
Not yet recruitingNCT07445672cyclophotocoagUpdated Mar 27, 2026

Propofol Versus Sevoflurane Anesthesia on the Intraocular Pressure and Hemodynamics in Patient Undergoing Cyclophotocoagulation

An interventional study of Propofol and Fentanyl administration and Sevoflurane and fentanyl administration in Patient Cataract, sponsored by Sohag University. Not yet recruiting at 1 site in Egypt. Open to participants aged 15 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-03-27.

Sponsored by Sohag University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Jun 2026, 3 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
15 Years to 50 Years
Sex
All
01

Study summary

we use two different technique of anaesthesia for anaesthesia of patient undergoining CPC operation (20 each) were comparable with regard to demographic data and hemodynamic variables, IOP. After approval by our local Ethics Committee and written informed consent, 40 ASA physical status I, II or III patients scheduled for elective CBC operations were included in this study group s anasthetized with sevofluran while group p anaesthetized with propofol with repeated measurment of intraocular pressure of the other eye to detect which method better for IOP.

02

Conditions studied

  • Patient Cataract

Keywords

  • anaesthesia effect on IOP
03

In context

Lead sponsor

Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

ASA I to III

Exclusion criteria

Exclusion Criteria:

  • known allergies; adverse reactions to any of the anesthetic agents used in the study
  • unstable angina or manifest congestive heart failure.
  • airway management was expected to be difficult
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    group P patient anaesthetized by propofol

    glaucoma patient anaesthetized by propofol in induction and maintenance with fentanyl and cisatracurium as muscle relaxant during cyclophotocoagulation operation

    Drug: Propofol and Fentanyl administration

  • Active comparator
    Grpoup S patient anesthetized by sevoflurane

    glaucoma patient anaesthetized by Sevoflurane in induction and maintenance with fentanyl and cisatracurium as muscle relaxant during cyclophotocoagulation operation

    Drug: Sevoflurane and fentanyl administration

Interventions

  • DrugPropofol and Fentanyl administration

    Group P patient anaesthetized by propofol and fentanyle for induction and maintenance

  • DrugSevoflurane and fentanyl administration

    Group S patient anaesthetized by sevoflurane and fentanyl for induction and maintenance

06

What researchers measure

Primary outcomes

  1. measurement of Intra ocular pressure during different type of anesthesia

    Time frame: 2 minute after administration of muscle relaxant and every 5 minute until termination of surgery

07

Study locations

1 site
  • Suhag faculty of medicine
    Sohag, Sohag Governorate, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07445672
Lead sponsor
Sohag University
Responsible party
Waleed Adel Ahmed (lecturer of anaesthesia and intensive care, Sohag University) — Principal investigator
First posted
Mar 3, 2026
Start date
Mar 1, 2026 (estimated)
Primary completion
Jun 10, 2026 (estimated)
Completion
Jul 20, 2026 (estimated)
Last update
Mar 27, 2026

Study contacts

waleed adel Ahmed, lecturer
Contact
waleidadel8514@gmail.com
00201006392210

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion